Author:
Elezbawy Baher,Fasseeh Ahmad Nader,Németh Bertalan,Gamal Mary,Eldebeiky Mariam,Refaat Remonda,Taha Amr,Rabiea Shimaa,Abdallah Marwa,Ramadan Soha,Noaman Hasnaa,Eldin Amany Bahaa,Mostafa Hossam,Nouh Sara,Zaki Asmaa,Abdelrahman Mohamed,Abaza Sherif,Kalò Zoltàn
Abstract
Abstract
Background
With the availability of several similar medical devices performing the same function, choosing one for reimbursement is not easy, especially if purchased for a large number of patients. The objective of this project was to create a multicriteria decision analysis (MCDA) tool, that captures and compares all implantable medical devices’ attributes, to provide an objective method for choosing among the available options in Egypt.
Method
We conducted a systematic review and expert interviews, to identify the relevant criteria for inclusion in the tool. Subsequently, a workshop was conducted, that involved experts in procuring and tendering medical devices. Experts chose the criteria, ranked them, assigned weights and scoring functions for each criterion, and then created the draft tool. A pilot phase followed; then, another workshop was conducted to fine-tune the tool. We readjusted the tool based on experts’ experience with the draft tool.
Results
The final tool included eight criteria, arranged according to their weightage: technical characteristics (29.4%), country of origin (19.5%), use in reference countries (14.9%), supply reliability (11.7%), previous use in tenders (9.0%), instant replacement within product variety (6.9%), pharmacovigilance (4.6%), and refund or replacement (4.0%). Each medical device was assessed on these eight criteria to achieve a final score, that was compared to the alternative devices’ scores. Price is not included in the MCDA tool, but it will be added in the financial evaluation phase.
Conclusion
Decisionmakers could use the MCDA tool, to make evidence-based and objective decisions for purchasing implantable devices, in the Egyptian public sector. Post price evaluation, the product with the best value will be chosen for reimbursement.
Highlights
We created an MCDA tool to help decision makers choose between alternative implantable medical devices in Egypt.
The MCDA tool includes eight criteria, where price is evaluated as a separate step.
“Technical characteristics” and “country of origin” criteria carried the highest weights, thus representing approximately 50% of the decision.
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Health Policy,Computer Science Applications
Reference21 articles.
1. Jin JFDA. FDA authorization of medical devices. JAMA. 2014;311:435. https://doi.org/10.1001/jama.2013.286274.
2. World Health Organization. Medical devices. 2022. https://www.who.int/health-topics/medical-devices#tab=tab_1. Accessed 19/4/2022.
3. Health Products Regulatory Authority. Implantable medical devices. 2022. http://www.hpra.ie/homepage/medical-devices/safety-information/consumer-advice/implantable-medical-devices. Accessed 13/4/2022.
4. ECRI. Device evaluations. 2022. https://www.ecri.org/solutions/device-evaluations. Accessed 19/4/2022.
5. Tallarico S, Aloini D, Dulmin R, Lazzini S, Mininno V, Pellegrini L. Health technology assessment of medical devices. Overcoming the critical issues of current assessment. J Multi Criteria Decis Anal. 2022;29:150–72. https://doi.org/10.1002/mcda.1764.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献